[1]
|
Herder GJM, Verboom P, Smit EF, et al. Practice, efficacy and cost of staging suspected non-small cell lung cancer:a retrospective study in two Dutch hospitals[J]. Thorax, 2002, 57(1):11-14. |
[2]
|
Hany TF, Steinert HC, Goerres GW, et al. PET diagnostic accuracy:improvement with in-line PET-CT system:initial results[J]. Radiology, 2002, 225(2):575-581. |
[3]
|
Cohade C, Osman M, Pannu HK, et al. Uptake in supraclavicular area fat("USA-Fat"):description on 18F-FDGPET-CT[J]. J Nucl Med,2003, 44(2):170-176. |
[4]
|
Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron emission tomography and computed tomography[J]. N Engl J Med, 2003, 348(25):2500-2507. |
[5]
|
Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer:dual-modality PET-CT in preoperative staging[J]. Radiology, 2003,229(2):526-533. |
[6]
|
Marom EM, McAdams HP, Erasmus JJ, et al. Staging non-small cell lung cancer with whole-body PET[J]. Radiology, 1999, 212(3):803-809. |
[7]
|
Keidar Z, Haim N, Guralnik L, et al. PET-CT using 18F-FDG in suspected lung cancer recurrence:diagnostic value and impact on patient management[J]. J Nucl Med, 2004, 45(10):1640-1646. |
[8]
|
Caldwell CB, Mah K, Ung YC, et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small cell lung tumors on CT:the impact of 18FDG-hybrid PET fusion[J].Int J Radiat Oncol Biol Phys, 2001, 51(4):923-931. |
[9]
|
Erdi YE, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET)[J]. Radiother Oncol, 2002,62(1):51-60. |
[10]
|
Ciernik, IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography(PET-CT):a feasibility study[J]. Int J Radiat Oncol Biol Phys,2003, 57(3):853-863. |
[11]
|
Goerres GW, Kamel E, Seifert B, et al. Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET-CT system[J]. J Nucl Med, 2002,43(11):1469-1475. |
[12]
|
Osman MM, Cohade C, Nakamoto Y, et al. Clinically significant inaccurate localization of lesions with PET-CT:frequency in 300patients[J]. J Nucl Med, 2003, 44(2):240-243. |
[13]
|
Goerres GW, Kamel E, Heidelberg TN, et al. PET-CT image coregistration in the thorax:influence of respiration[J]. Eur J Nucl Med Mol Imaging, 2002, 29(3):351-60. |
[14]
|
Beyer T, Blodgett T, Blodgett T, et al. Dual-modality PET-CT imaging:the effect of respiratory motion on eombinod image quality in clinical oncology[J]. Eur J Nucl Med Mol Imaging, 2003, 30(4):588-596. |
[15]
|
Osman, MM, Cohade C, Nakamoto Y, et al. Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT[J]. Eur J Nucl Med Mol Imaging, 2003, 30(4):603-606. |
[16]
|
Nehmeh SA, Erdi YE, Pan T, et al. Quantitation of respiratory motion during 4D-PET-CT acquisition[J]. Med Phys, 2004, 31(6):1333-1338. |
[17]
|
Antoch G, Freudenberg LS, Beyer T, et al. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18FFDG PET-CT[J]. J Nucl Med, 2004, 45(1):56s-65s. |
[18]
|
Nakamoto Y, Chin BB, Kraitchman DL, et al. Effects of nonionic intravenous contrast agents at PET-CT imaging:phantom and canine studies[J]. Radiology, 2003, 227(3):817-824. |
[19]
|
Hara T, Kosaka N, Suzuki T, et al. Uptake rates of (18)F-fluorodeoxyglucose and (11)C-choline in lung cancer and pulmonary tuberculosis:a positron emission tomography study[J]. Chest, 2003,124(3):893-895. |
[20]
|
Pieterman RM, Que TH, Elsinga PH. Comparison of (11)C-choline and(18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer[J]. J Nucl Med, 2002, 43(2):167-172. |